Neuropediatrics 2000; 31(4): 186-189
DOI: 10.1055/s-2000-7460
Original Article

Georg Thieme Verlag Stuttgart · New York

Congenital Muscular Dystrophy with Secondary Merosin Deficiency and Normal Brain MRI: A Novel Entity?

E. Mercuri1 , Caroline A. Sewry1,3 , Susan C. Brown1 , M. Brockington1 , H. Jungbluth1 , Catherine DeVile1 , Serena Counsell2 , A. Manzur1 , F. Muntoni1
  • 1 Dubowitz Neuromuscular Centre, Department of Paediatrics, Hammersmith Hospital, London, UK
  • 2 Robert Steiner MRI Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK
  • 3 Department of Pathology, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Oswestry, UK
Further Information

Publication History

Publication Date:
31 December 2000 (online)

We describe two Scottish siblings affected by a form of congenital muscular dystrophy characterised by a severe clinical phenotype, similar to that observed in the 6q-linked merosin-deficient CMD but in whom brain MRI and cognitive development were normal. The maximal function achieved in the 2 siblings was sitting independently. Serum CK were grossly elevated and the skin and muscle biopsies showed a severe reduction of merosin in both. The normal brain MRI and normal cognitive development distinguish this form from Fukuyama congenital muscular dystrophy, muscle-eye-brain disease or other forms of CMD with secondary partial merosin deficiency and abnormal brain MRI and/or mental retardation. Linkage analysis excluded all the known loci for CMD. We propose that this may represent a novel variant of CMD.

References

  • 1 Allamand V, Sunada Y, Salih M AM, Starub V, Ozo C O, Al-Turaiki M HS, Akbar M, Kolo T, Colognato H, Zhang X, Sorokin L M, Yurchenco P D, Tryggvason K, Campbell K P. Mild congenital muscular dystrophy in two patients with an internally deleted laminin 2 chain.  Hum Mol Genet. 1997;  6 747-752
  • 2 Brett F M, Costigan D, Farrell M A, Heaphy P, Thornton J, King M D. Merosin-deficient congenital muscular dystrophy and cortical dysplasia.  Eur J Paed Neurol. 1998;  2 77-82
  • 3 Brockington M, Sewry C A, Herrmann R, Naom I, Dearlove A, Rhodes M, Topaloglu H, Dubowitz V, Voit T, Muntoni F. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1 q42.  Am J Hum Genet. 2000;  66 428-435
  • 4 Cohn R D, Herrmann R, Sorkin L, Wever U, Voit T. Laminin 2 chain deficient congenital muscular dystrophy. Variable epitope expression in severe and mild cases.  Neurology. 1998;  51 94-101
  • 5 Cormand B, Avela K, Pihko H, Santavuori P, Talim B, Topaloglu H, de la Chapelle A, Lehesjoki A E. Assignment of the muscle-eye-brain disease gene to 1 p32-p34 by linkage analysis and homozygosity mapping.  Am J Hum Genet. 1999;  64 126-135
  • 6 Dubowitz V. 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14 - 16 May 1993.  Neuromusc Disord. 1994;  4 75-81
  • 7 Dubowitz V, Fardeau M. Workshop report: 27th ENMC sponsored workshop on congenital muscular dystrophy, 22 - 24 April 1994, The Netherlands.  Neuromusc Disord. 1995;  5 253-258
  • 8 Helbling-Leclerc A, Topaloglu H, Tomè F MS, Sewry C, Gyapay G, Naom I, Muntoni F, Dubowitz V, Barois A, Estournet B, Urtizberea J A, Weissenbach J, Schwartz K, Fardeau M, Guicheney P. Readjusting the localisation of merosin (laminin α2 chain) deficiency congenital muscular dystrophy locus on chromosome 6 q2.  C R Acad Sci Paris/Life Sciences. 1995;  318 1245-1252
  • 9 Hermann R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy with laminin 2 chain deficiency, identification of a new intermediate phenotype and correlation of clinical findings to muscle immunochemistry.  Eur J Paediat. 1996;  155 968-976
  • 10 Hillaire D, Leclerc A, Faure C, Topaloglu H, Chiannilkulchai N, Guicheney P, Grinas L, Legos P, Philpot J, Evangelista T, Routon M C, Mayer M, Pellissier J F, Estournet B, Barois A, Hentati F, Feingold N, Beckmann J S, Dubowitz V, Tomè F MS, Fardeau M. Localisation of merosin negative congenital muscular dystrophy to chromosome 6 q22 by homozygosity mapping.  Hum Mol Genet. 1994;  3 1657-1661
  • 11 Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagome Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda T. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy.  Nature. 1998;  394 388-392
  • 12 Mora M, Moroni I, Uziel G, Di Blasi C, Barresi R, Farina L, Morandi L. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities.  Neuromusc Disord. 1996;  5 377-381
  • 13 Naom I, D'Alessandro M, Sewry C, Philpot J, Manzur A Y, Dubowitz V, Muntoni F. Laminin α2 chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy.  Neuromusc Disord. 1998;  8 495-501
  • 14 Naom I, D'Alessandro M, Topaloglu H, Sewry C, Ferlini A, Helbling-Leclerc A, Guicheney P, Weissenbach J, Schwartz K, Bushby K, Philpot J, Dubowitz V, Muntoni F. Refinement of the laminin α2 chain locus to human chromosome 6 q2 in severe and mild merosin-deficient congenital muscular dystrophy.  J Med Genet. 1997;  34 99-104
  • 15 Naom I, D'Alessandro M, Sewry C, Jardine P, Ferlini A, Moss T, Dubowitz V, Muntoni F. Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy.  Brain. 2000;  123 31-41
  • 16 Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.  Neuromusc Disord. 1995;  5 301-305
  • 17 Philpot J, Bagnall A, King C, Dubowitz V, Muntoni F. Feeding problems in merosin deficient congenital muscular dystrophy.  Arch Dis Child. 1999;  80 542-547
  • 18 Philpot J, Cowan F, Pennock J, Sewry C, Dubowitz V, Bydder G, Muntoni F. Merosin deficient congenital muscular dystrophy: the spectrum of brain lesions on magnetic resonance imaging.  Neuromusc Disord. 1999;  9 81-85
  • 19 Pini A, Merlini L, Tome F MS, Chevalley M, Gobbi G. Merosin negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report from three Italian cases in two families.  Brain Dev. 1996;  18 316-322
  • 20 Sewry C A, D'Alessandro M, Wilson L A, Sorokin L M, Naom I, Bruno S, Ferlini A, Dubowitz V, Muntoni F. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.  Neuropediatrics. 1997;  28 217-222
  • 21 Sewry C A, Naom I, D'Alessandro M, Sorokin L, Bruno S, Wilson L A, Dubowitz V, Muntoni F. Variable phenotype in merosin-deficient congenital muscular dystrophy and differential immunolabelling of two fragments of the laminin α2 chain.  Neuromusc Disord. 1997;  7 169-175
  • 22 Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy.  J Child Neurol. 1995;  10 472-475
  • 23 Tan E, Topaloglu H, Sewry C, Zorlu Y, Naom I, Erdem S, D'Alessandro M, Muntoni F, Dubowitz V. Late onset muscular dystrophy with cerebral hypomyelination due to partial merosin deficiency.  Neuromusc Disord. 1997;  7 85-89
  • 24 Topaloglu H, Talim B, Vignier N, Helbling-Leclerc A H, Yetuk M, Afsin I E, Caglar M, Kale G, Guicheney P. Merosin-deficient congenital muscular dystrophy with severe mental retardation and normal cranial MRI: a report of two siblings.  Neuromusc Disord. 1998;  8 169-174
  • 25 Voit T. Congenital muscular dystrophies: 1997 update.  Brain Dev. 1998;  20 65-74

M. D., Ph. D. Eugenio Mercuri

Department of Paediatrics Hammersmith Hospital

Du Cane Road

London W12 OHN

UK

Email: E-mail: e.mercuri@ic.ac.uk

    >